Table 1.

Baseline characteristics

	All (n = 28)	Mortality group (n = 5)	No-mortality group (n = 23)	p value
Sex				0.780*
Male	21 (75)	4 (80)	17 (74)
Female	7 (25)	1 (20)	6 (26)
Median age ± SD, years	60.1±13.6	69±5.4	58±14	0.011**
IBD type				0.690*
Ulcerative colitis	24 (86)	4 (80)	20 (87)
Crohn's disease	4 (14)	1 (20)	3 (13)
IBD therapy
Steroid	25 (90)	5 (100)	20 (87)	0.390
Thiopurine	17 (60)	4 (80)	13 (57)	0.330*
Calcineurin inhibitor	7 (25)	2 (40)	5 (22)	0.390*
Anti-TNF	10 (36)	0 (0)	10 (44)	0.066*
Laboratory data
Lymphocytes ± SD, /µL	1,361±648	1,077±522	1,406±667	0.400**
Albumin ± SD, g/dL	3.3±0.73	2.6±0.81	3.5±0.62	0.090**
C-reactive protein ± SD, mg/dL	2.3±3.4	2.9±2.0	2.2±3.7	0.560**
IBD activity
Mayo score ± SD	7.3±2.1
Crohn's Disease Activity Index ± SD	310±114
Days ± SD to start steroid treatment	4.0±3.9	2.2±1.3	4.4±4.2	0.063**

Values are n (%) unless otherwise indicated. IBD, inflammatory bowel disease; SD, standard deviation.

^*χ²test.

^**Student's t test.